BROWN ADVISORY INC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.

Quarter-by-quarter ownership
BROWN ADVISORY INC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$3,465,000
+65.5%
27,568
+78.6%
0.01%
+42.9%
Q4 2018$2,094,000
-11.3%
15,439
+79.5%
0.01%0.0%
Q3 2018$2,361,000
+18.0%
8,601
-11.0%
0.01%
+16.7%
Q2 2018$2,001,000
+52.7%
9,661
+21.7%
0.01%
+50.0%
Q1 2018$1,310,000
+10.9%
7,936
-8.0%
0.00%0.0%
Q4 2017$1,181,000
-2.8%
8,623
-3.4%
0.00%0.0%
Q3 2017$1,215,000
+16.5%
8,925
+3.8%
0.00%
+33.3%
Q2 2017$1,043,000
+32.9%
8,596
+15.9%
0.00%0.0%
Q1 2017$785,000
+34.9%
7,416
+29.4%
0.00%
+50.0%
Q4 2016$582,000
+26.2%
5,730
+26.8%
0.00%0.0%
Q3 2016$461,000
+17.9%
4,520
+37.8%
0.00%
+100.0%
Q2 2016$391,000
-19.9%
3,279
-28.1%
0.00%
-50.0%
Q1 2016$488,000
-1.4%
4,559
-0.2%
0.00%0.0%
Q4 2015$495,000
+18.7%
4,569
-6.0%
0.00%
+100.0%
Q3 2015$417,000
+16.2%
4,861
+36.5%
0.00%0.0%
Q2 2015$359,000
-22.1%
3,560
-40.4%
0.00%0.0%
Q1 2015$461,000
+67.0%
5,976
+15.5%
0.00%0.0%
Q4 2014$276,000
+30.8%
5,176
+15.6%
0.00%0.0%
Q3 2014$211,000
-0.5%
4,476
+31.6%
0.00%0.0%
Q2 2014$212,000
-4.5%
3,400
+3.0%
0.00%0.0%
Q1 2014$222,0003,3000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders